Head-to-head · WeighScore
GoodRx vs Welling Health
The verdict
GoodRx takes it — 69.6/100 to 68.3/100, but only just.
GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. Welling Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GoodRx | Welling Health |
|---|---|---|
| WeighScore | 69.6/100 | 68.3/100 |
| Grade | C | C |
| Scorecard rank | #116 | #149 |
| Semaglutide | Not disclosed | $190/mo (compounded) |
| Tirzepatide | $299/mo (brand Zepbound) | $275/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #116 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Graded #149 · C
Strengths
- Transparent flat monthly rate — $190 semaglutide / $275 tirzepatide, all doses, no insurance or hidden fees
- LegitScript-certified 503A pharmacy with US-licensed clinicians in all 50 states and a named legal entity
- Streak discounts cut up to 30% — semaglutide as low as $133/month for logging meals consistently
- Free shipping, free AI macro-tracker app, and 24-hour intake review
Where it loses points
- Tirzepatide at $275/month is higher than the cheapest compounded competitors
- The streak discount requires daily in-app meal logging — miss days and you pay full rate
- The compounding pharmacy partner is described as a LegitScript-certified 503A but not named
- Only two medications — compounded semaglutide and tirzepatide; no oral or non-GLP options
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.